Successful revascularization improves long-term clinical outcome in patients with chronic coronary total occlusion

Tomohiko Teramoto1, Etsuo Tsuchikane1, Masanori Yamamoto1

  • 1Department of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Aichi, Japan.

Insights

Successful percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) significantly reduces long-term mortality. This study highlights the benefits of CTO revascularization for patient survival.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) techniques for chronic total occlusions (CTOs) have advanced, improving initial success rates.
  • Limited data exists on the long-term mortality impact of successful CTO revascularization in Japan.

Purpose of the Study:

  • To compare long-term clinical outcomes between successful and failed CTO PCI.
  • To identify factors associated with clinical outcomes in CTO revascularization.

Main Methods:

  • Retrospective analysis of 738 patients undergoing CTO-PCI between 2006 and 2013.
  • Patients were categorized into successful (n=656) and failed (n=82) revascularization groups.
  • Exclusion criteria included second-attempt success, small branches, and multi-vessel CTOs. Survival assessed via follow-up.

Main Results:

  • Initial angiographic success rate was 88.9%.
  • Successful CTO-PCI was associated with significantly lower cumulative all-cause mortality (p=0.0003).
  • The rate of evident cardiac death was substantially lower in the success group (3.5% vs. 15.9%, p<0.0001).

Conclusions:

  • Successful revascularization of chronic total occlusions significantly improves long-term clinical outcomes.
  • CTO revascularization is a crucial strategy for reducing mortality in affected patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347